Kurt Karst is speaking at ACI Life Sciences IP Due Diligence Conference

Understanding the Impact of New Developments at FDA on the IP Due Diligence Review Process

When

November 14-15, 2019

Where

OMNI Parker House
Boston, MA

For more information see conference website

Professionals
Related Professionals